MCID: PLL001
MIFTS: 59

Pallister-Hall Syndrome

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Pallister-Hall Syndrome

MalaCards integrated aliases for Pallister-Hall Syndrome:

Name: Pallister-Hall Syndrome 53 12 23 49 24 71 36 28 13 51 41 14 69
Phs 53 49 24 71
Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly 53 49
Hypothalamic Hamartoblastoma Hypopituitarism Imperforate Anus and Postaxial Polydactyly 71
Pallister Hall Syndrome 49
Hall-Pallister Syndrome 24
Phy 72

Characteristics:

OMIM:

53
Inheritance:
autosomal dominant

Miscellaneous:
variable expressivity
variable severity


HPO:

31
pallister-hall syndrome:
Mortality/Aging neonatal death
Onset and clinical course variable expressivity
Inheritance autosomal dominant inheritance


GeneReviews:

23
Penetrance No instances of incomplete penetrance of phs have been published...

Classifications:



Summaries for Pallister-Hall Syndrome

NIH Rare Diseases : 49 Pallister-Hall syndrome (PHS) is a genetic disease that affects the development of many parts of the body. Common features include extra fingers and/or toes (polydactyly), extra skin between the fingers or toes (syndactyly), an abnormal growth in the brain called a hypothalamic hamartoma, and a malformation of the airway known as bifid epiglottis. The bifid epiglottis in rare cases may lead to respiratory failure. While the hypothalamic hamartoma in most cases does not cause problems, in some cases it may cause neurological problems such as seizures, growth hormone deficiency, precocious puberty, or a deficiency of many hormones (panhypopituitarism) that can result in cortisol deficiency. Other symptoms of PHS may include imperforate anus, abnormalities in the kidneys, heart defects, small genitalia, lack of fingers, nail problems, cleft palate, bifid uvula, and development delay and behavioral problems.  Pallister-Hall syndrome is caused by mutations in the GLI3 gene. Inheritance is autosomal dominant, however, in about a quarter of cases Pallister-Hall syndrome results from a new (de novo) mutation. The diagnosis of Pallister-Hall syndrome can be made when there is a hypothalamic hamartoma and polydactyly. The genetic test that identifies a mutation in the GLI3 gene confirms the diagnosis. Treatment is based on the symptoms, and may include medication for the early treatment of cortisol deficiency and seizures, surgery for imperforate anus and/or polydactyly, and special education when developmental delays are present. The prognosis depends on which symptoms are present and their severity. Last updated: 11/20/2017

MalaCards based summary : Pallister-Hall Syndrome, also known as phs, is related to anus, imperforate and mckusick-kaufman syndrome, and has symptoms including seizures, macrocephaly and hypertelorism. An important gene associated with Pallister-Hall Syndrome is GLI3 (GLI Family Zinc Finger 3), and among its related pathways/superpathways are Hedgehog signaling pathway and Pathways in cancer. The drug Menthol has been mentioned in the context of this disorder. Affiliated tissues include pituitary, kidney and skin, and related phenotypes are cellular and growth/size/body region

OMIM : 53 Pallister-Hall syndrome is a pleiotropic autosomal dominant disorder comprising hypothalamic hamartoma, pituitary dysfunction, central polydactyly, and visceral malformations (Biesecker et al., 1996). (146510)

UniProtKB/Swiss-Prot : 71 Pallister-Hall syndrome: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia.

Genetics Home Reference : 24 Pallister-Hall syndrome is a disorder that affects the development of many parts of the body. Most people with this condition have extra fingers and/or toes (polydactyly), and the skin between some fingers or toes may be fused (cutaneous syndactyly). An abnormal growth in the brain called a hypothalamic hamartoma is characteristic of this disorder. In many cases, these growths do not cause any health problems; however, some hypothalamic hamartomas lead to seizures or hormone abnormalities that can be life-threatening in infancy. Other features of Pallister-Hall syndrome include a malformation of the airway called a bifid epiglottis, an obstruction of the anal opening (imperforate anus), and kidney abnormalities. Although the signs and symptoms of this disorder vary from mild to severe, only a small percentage of affected people have serious complications.

Wikipedia : 72 Pallister–Hall syndrome is a disorder that affects the development of many parts of the... more...

GeneReviews: NBK1465

Related Diseases for Pallister-Hall Syndrome

Diseases related to Pallister-Hall Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 87)
# Related Disease Score Top Affiliating Genes
1 anus, imperforate 30.8 GLI3 SHH
2 mckusick-kaufman syndrome 30.3 GLI3 MKKS
3 greig cephalopolysyndactyly syndrome 30.3 GLI2 GLI3 KIF7
4 hydrolethalus syndrome 1 29.9 HYLS1 KIF7 SHH
5 polydactyly 29.6 GLI2 GLI3 MKKS SHH
6 hypothalamic hamartomas 11.7
7 pulmonary hypertension 11.5
8 paroxysmal hemicrania 11.5
9 culler-jones syndrome 11.5
10 lactic acidosis 11.3
11 leukemia, chronic myeloid 11.2
12 hyperoxaluria, primary, type iii 11.2
13 metabolic acidosis 11.1
14 helicobacter pylori infection 11.1
15 bartter disease 11.1
16 renal tubular acidosis, distal 11.1
17 hyperphenylalaninemia, bh4-deficient, d 11.1
18 acid sphingomyelinase deficiency 10.9
19 pitt-hopkins syndrome 10.9
20 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.6
21 nodular medulloblastoma 10.2 GLI1 GLI2
22 holoprosencephaly 4 10.2 GLI3 SHH
23 acrocallosal syndrome 10.2 GLI3 KIF7
24 polydactyly, preaxial iv 10.1
25 renal hypodysplasia/aplasia 1 10.1
26 smith-lemli-opitz syndrome 10.1
27 opitz gbbb syndrome, type i 10.1
28 corpus callosum, agenesis of, with abnormal genitalia 10.1
29 hydronephrosis 10.1
30 hypoparathyroidism 10.1
31 epilepsy 10.1
32 laryngitis 10.1
33 hypopituitarism 10.1
34 disuse amblyopia 10.1 GLI2 SHH
35 gastric squamous cell carcinoma 10.1 GLI1 SHH
36 gastric tubular adenocarcinoma 10.0 GLI1 SHH
37 bardet-biedl syndrome 17 10.0 GLI2 SHH
38 keratocystic odontogenic tumor 10.0 GLI1 SHH
39 central nervous system tuberculosis 10.0 GLI1 SHH
40 adult medulloblastoma 10.0 GLI1 SHH
41 agnathia-otocephaly complex 10.0 GLI2 SHH
42 tracheoesophageal fistula 10.0 GLI3 SHH
43 esophageal atresia 9.9 GLI2 GLI3 SHH
44 sarcoma 9.9
45 malignant pleural mesothelioma 9.9
46 soft tissue sarcoma 9.9
47 hypothyroidism, thyroidal or athyroidal, with spiky hair and cleft palate 9.8 GLI1 GLI2 SHH
48 integumentary system cancer 9.8 GLI1 GLI2 SHH
49 bardet-biedl syndrome 1 9.8 KIF7 MKKS
50 joubert syndrome 1 9.8 HYLS1 KIF7 SHH

Graphical network of the top 20 diseases related to Pallister-Hall Syndrome:



Diseases related to Pallister-Hall Syndrome

Symptoms & Phenotypes for Pallister-Hall Syndrome

Symptoms via clinical synopsis from OMIM:

53
Head And Neck Nose:
short nose
anteverted nares
flat nasal bridge

Growth Height:
short stature

Genitourinary Internal Genitalia Male:
cryptorchidism
testicular hypoplasia

Head And Neck Eyes:
microphthalmia

Skin Nails Hair Nails:
nail dysplasia

Skeletal Hands:
oligodactyly
syndactyly
postaxial polydactyly
short 4th metacarpals

Respiratory Lung:
abnormal lung lobation

Skin Nails Hair Skin:
midline facial capillary hemangioma

Genitourinary Kidneys:
renal dysplasia
renal ectopia

Neurologic Central Nervous System:
hypothalamic hamartoma
holoprosencephaly (less common)
pituitary aplasia or dysplasia

Respiratory Larynx:
bifid epiglottis
laryngeal cleft
hypoplastic epiglottis

Skeletal Pelvis:
dislocated hips

Head And Neck Teeth:
natal teeth

Head And Neck Ears:
microtia
posteriorly rotated ears
simple auricles
absent external auditory canals

Cardiovascular Vascular:
patent ductus arteriosus

Growth Other:
intrauterine growth retardation

Cardiovascular Heart:
ventricular septal defect
proximal aortic coarctation

Skeletal Spine:
hemivertebrae

Endocrine Features:
panhypopituitarism
adrenal gland hypoplasia
thyroid dysplasia/aplasia

Genitourinary External Genitalia Male:
micropenis

Skeletal Feet:
syndactyly
postaxial polydactyly

Head And Neck Mouth:
microglossia
multiple buccal frenula
cleft lip and palate

Skeletal Limbs:
distal shortening of limbs
radial subluxation

Abdomen Gastroin testinal:
imperforate anus

Chest RibsSternum Clavicles And Scapulae:
fused ribs


Clinical features from OMIM:

146510

Human phenotypes related to Pallister-Hall Syndrome:

31 (show top 50) (show all 118)
# Description HPO Frequency HPO Source Accession
1 seizures 31 HP:0001250
2 macrocephaly 31 frequent (33%) HP:0000256
3 hypertelorism 31 frequent (33%) HP:0000316
4 ptosis 31 frequent (33%) HP:0000508
5 precocious puberty 31 occasional (7.5%) HP:0000826
6 intellectual disability 31 very rare (1%) HP:0001249
7 respiratory insufficiency 31 very rare (1%) HP:0002093
8 inguinal hernia 31 occasional (7.5%) HP:0000023
9 global developmental delay 31 very rare (1%) HP:0001263
10 skeletal dysplasia 31 frequent (33%) HP:0002652
11 depressed nasal bridge 31 occasional (7.5%) HP:0005280
12 umbilical hernia 31 occasional (7.5%) HP:0001537
13 short nose 31 frequent (33%) HP:0003196
14 microtia 31 very rare (1%) HP:0008551
15 anteverted nares 31 occasional (7.5%) HP:0000463
16 short stature 31 frequent (33%) HP:0004322
17 broad thumb 31 frequent (33%) HP:0011304
18 cleft palate 31 occasional (7.5%) HP:0000175
19 ectopic kidney 31 occasional (7.5%) HP:0000086
20 patent ductus arteriosus 31 occasional (7.5%) HP:0001643
21 cryptorchidism 31 occasional (7.5%) HP:0000028
22 intrauterine growth retardation 31 frequent (33%) HP:0001511
23 short 4th metacarpal 31 occasional (7.5%) HP:0010044
24 atrial septal defect 31 occasional (7.5%) HP:0001631
25 coarctation of aorta 31 occasional (7.5%) HP:0001680
26 primary adrenal insufficiency 31 occasional (7.5%) HP:0008207
27 hip dislocation 31 frequent (33%) HP:0002827
28 cerebellar hypoplasia 31 occasional (7.5%) HP:0001321
29 depressed nasal ridge 31 frequent (33%) HP:0000457
30 microphthalmia 31 very rare (1%) HP:0000568
31 hypospadias 31 occasional (7.5%) HP:0000047
32 decreased testicular size 31 occasional (7.5%) HP:0008734
33 low-set, posteriorly rotated ears 31 frequent (33%) HP:0000368
34 downslanted palpebral fissures 31 frequent (33%) HP:0000494
35 brachydactyly 31 frequent (33%) HP:0001156
36 anal atresia 31 frequent (33%) HP:0002023
37 renal hypoplasia 31 HP:0000089
38 choanal atresia 31 occasional (7.5%) HP:0000453
39 ventricular septal defect 31 occasional (7.5%) HP:0001629
40 arrhinencephaly 31 very rare (1%) HP:0002139
41 nail dysplasia 31 frequent (33%) HP:0002164
42 oligohydramnios 31 very rare (1%) HP:0001562
43 holoprosencephaly 31 occasional (7.5%) HP:0001360
44 hemivertebrae 31 very rare (1%) HP:0002937
45 microretrognathia 31 occasional (7.5%) HP:0000308
46 ambiguous genitalia 31 very rare (1%) HP:0000062
47 toe syndactyly 31 occasional (7.5%) HP:0001770
48 cleft upper lip 31 occasional (7.5%) HP:0000204
49 hydronephrosis 31 HP:0000126
50 atresia of the external auditory canal 31 very rare (1%) HP:0000413

MGI Mouse Phenotypes related to Pallister-Hall Syndrome:

43 (show all 16)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.15 GLI2 GAS1 GLI3 GLI1 IGF1 SHH
2 growth/size/body region MP:0005378 10.1 GLI2 GAS1 GLI3 GLI1 MKKS IGF1
3 craniofacial MP:0005382 10.08 GLI2 GAS1 GLI3 GLI1 SHH KIF7
4 limbs/digits/tail MP:0005371 10.06 GLI2 IGF1 GAS1 GLI3 GLI1 SHH
5 cardiovascular system MP:0005385 10.03 GLI3 GAS1 MKKS IGF1 SHH KIF7
6 mortality/aging MP:0010768 10.03 GLI2 GAS1 GLI3 GLI1 MKKS IGF1
7 nervous system MP:0003631 10.01 GLI2 GAS1 GLI3 GLI1 IGF1 SHH
8 embryo MP:0005380 9.99 GLI2 GAS1 GLI3 GLI1 SHH KIF7
9 hearing/vestibular/ear MP:0005377 9.95 GLI2 IGF1 GAS1 GLI3 SHH MKKS
10 digestive/alimentary MP:0005381 9.92 GLI1 GLI3 GLI2 SHH KIF7
11 reproductive system MP:0005389 9.87 GLI2 GLI3 GLI1 IGF1 SHH KIF7
12 respiratory system MP:0005388 9.86 GLI2 IGF1 GAS1 GLI3 GLI1 SHH
13 no phenotypic analysis MP:0003012 9.77 GLI1 GLI3 GLI2 SHH KIF7
14 skeleton MP:0005390 9.63 GLI2 GAS1 GLI3 IGF1 SHH KIF7
15 taste/olfaction MP:0005394 9.13 GLI3 MKKS SHH
16 vision/eye MP:0005391 9.1 GLI2 GAS1 GLI3 MKKS SHH KIF7

Drugs & Therapeutics for Pallister-Hall Syndrome

Drugs for Pallister-Hall Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Menthol Approved 2216-51-5 16666

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Phenotype and Etiology of Pallister-Hall Syndrome Completed NCT00001404

Search NIH Clinical Center for Pallister-Hall Syndrome

Cochrane evidence based reviews: pallister-hall syndrome

Genetic Tests for Pallister-Hall Syndrome

Genetic tests related to Pallister-Hall Syndrome:

# Genetic test Affiliating Genes
1 Pallister-Hall Syndrome 28 GLI3

Anatomical Context for Pallister-Hall Syndrome

MalaCards organs/tissues related to Pallister-Hall Syndrome:

38
Pituitary, Kidney, Skin, Brain, Heart, Testes, Thyroid

Publications for Pallister-Hall Syndrome

Articles related to Pallister-Hall Syndrome:

(show top 50) (show all 64)
# Title Authors Year
1
Novel GLI3 variant causing overlapped Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS) phenotype with agenesis of gallbladder and pancreas. ( 29368652 )
2018
2
Pallister-Hall Syndrome. ( 29204208 )
2017
3
The early history of Pallister-Hall syndrome-Buried treasure of a sort. ( 26768579 )
2016
4
Bifid epiglottis in a patient with Pallister-Hall syndrome. ( 27339091 )
2016
5
Urogenital development in Pallister-Hall syndrome is disrupted in a cell-lineage-specific manner by constitutive expression of GLI3 repressor. ( 26604140 )
2016
6
Total colonic aganglionosis and imperforate anus in a severely affected infant with Pallister-Hall syndrome. ( 25604768 )
2015
7
Pallister-Hall syndrome has gone the way of modern medical genetics. ( 25424727 )
2014
8
Severe Pallister-Hall syndrome with persistent urogenital sinus, renal agenesis, imperforate anus, bilateral hypothalamic hamartomas, and severe skeletal anomalies. ( 23950073 )
2013
9
Pallister-Hall syndrome presenting as an intrauterine fetal demise at 39 weeks' gestation. ( 22499313 )
2012
10
Cochlear abnormality in a case of Pallister-Hall syndrome. ( 22890695 )
2012
11
Teaching NeuroImages: isolated hypothalamic hamartoma vs Pallister-Hall syndrome: imaging and clinical correlation. ( 22927681 )
2012
12
Transcallosal endoscopic resection of hypothalamic hamartoma in a case with Pallister-Hall syndrome. ( 21636348 )
2011
13
Positron emission tomography with glucose hypermetabolism of a hypothalamic hamartoma in infantile spasms associated with Pallister-Hall syndrome. ( 19793630 )
2010
14
Genital abnormalities in Pallister-Hall syndrome: Report of two patients and review of the literature. ( 21108399 )
2010
15
Fetal MRI of a hypothalamic hamartoma in Pallister-Hall syndrome. ( 20004865 )
2010
16
Giant diencephalic harmartoma and related anomalies: a newly recognized entity distinct from the Pallister-Hall syndrome. ( 19449422 )
2009
17
Hydrometrocolpos, postaxial polydactyly, and hypothalamic hamartoma in a patient with confirmed Pallister-Hall syndrome: a clinical overlap with McKusick-Kaufman syndrome. ( 18478223 )
2008
18
Genitourinary malformations as a feature of the Pallister-Hall syndrome. ( 16531732 )
2006
19
Pallister-Hall syndrome: unreported skeletal features of a GLI3 mutation. ( 16007608 )
2005
20
Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. ( 15739154 )
2005
21
Psychiatric and neuropsychological characterization of Pallister-Hall syndrome. ( 15617553 )
2005
22
Hypothalamic hamartomas and seizures: distinct natural history of isolated and Pallister-Hall syndrome cases. ( 15660767 )
2005
23
Gene symbol: GLI3. Disease: Pallister-Hall syndrome. ( 15046066 )
2004
24
Gonadal mosaicism in severe Pallister-Hall syndrome. ( 14708104 )
2004
25
Pallister-Hall syndrome with hypoparathyroidism. ( 15237717 )
2004
26
Gene symbol: GLI3. Disease: Pallister-Hall syndrome. ( 12575661 )
2003
27
Hirschprung's disease and imperforate anus in Pallister-Hall syndrome: a new association. ( 14523835 )
2003
28
Epilepsy and hypothalamic hamartoma: look at the hand Pallister-Hall syndrome. ( 12773293 )
2003
29
Gli 3 mutation in Pallister-Hall syndrome. ( 12017244 )
2002
30
Pallister-Hall syndrome phenotype in mice mutant for Gli3. ( 11978771 )
2002
31
Long-term treatment with growth hormone improves final height in a patient with Pallister-Hall syndrome. ( 11241471 )
2001
32
Pallister-Hall syndrome with stenosis of the cricoid cartilage and microphallus without hypopituitarism. ( 11693785 )
2001
33
Evidence for decreased growth hormone in patients with hypothalamic hamartoma due to Pallister-Hall syndrome. ( 11305791 )
2001
34
Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. ( 10982485 )
2000
35
Overlap of PIV syndrome, VACTERL and Pallister-Hall syndrome: clinical and molecular analysis. ( 10945658 )
2000
36
Pallister-Hall syndrome: clinical and MR features. ( 10588106 )
1999
37
Pallister-Hall syndrome. ( 9807095 )
1998
38
Pallister-Hall syndrome. ( 9615516 )
1998
39
Linkage mapping and phenotypic analysis of autosomal dominant Pallister-Hall syndrome. ( 9192261 )
1997
40
GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. ( 9054938 )
1997
41
Pallister-Hall syndrome. ( 8818945 )
1996
42
Exclusion of candidate loci and cholesterol biosynthetic abnormalities in familial Pallister-Hall syndrome. ( 8950676 )
1996
43
Report from the workshop on Pallister-Hall syndrome and related phenotypes. ( 8914745 )
1996
44
Polysyndactyly and asymptomatic hypothalamic hamartoma in mother and son: a variant of Pallister-Hall syndrome. ( 8591673 )
1995
45
Pallister-Hall syndrome and McKusick-Kaufmann syndrome: one entity? ( 7760322 )
1995
46
Hypothalamic hamartoma and the Pallister-Hall syndrome. ( 7577664 )
1995
47
Stringent delineation of Pallister-Hall syndrome in two long surviving patients: importance of radiological anomalies of the hands. ( 7473651 )
1995
48
Familial Pallister-Hall syndrome: three affected offspring. ( 7802025 )
1994
49
Autosomal dominant transmission of Pallister-Hall syndrome. ( 7894735 )
1994
50
Familial Pallister-Hall syndrome. ( 7880273 )
1994

Variations for Pallister-Hall Syndrome

UniProtKB/Swiss-Prot genetic disease variations for Pallister-Hall Syndrome:

71
# Symbol AA change Variation ID SNP ID
1 KIF7 p.Pro632Leu VAR_066450 rs115857753

ClinVar genetic disease variations for Pallister-Hall Syndrome:

6 (show all 33)
# Gene Variation Type Significance SNP ID Assembly Location
1 GLI3 NM_000168.5(GLI3): c.2062G> T (p.Glu688Ter) single nucleotide variant Pathogenic rs116840747 GRCh37 Chromosome 7, 42011977: 42011977
2 GLI3 NM_000168.5(GLI3): c.2139delC (p.Cys713Terfs) deletion Pathogenic rs116840749 GRCh38 Chromosome 7, 41967888: 41967888
3 GLI3 NM_000168.5(GLI3): c.2157delC (p.Ile720Serfs) deletion Pathogenic rs116840752 GRCh37 Chromosome 7, 42007468: 42007468
4 GLI3 NM_000168.5(GLI3): c.2346_2356delGCTAAAACAAG (p.Arg782Serfs) deletion Pathogenic rs116840756 GRCh37 Chromosome 7, 42007269: 42007279
5 GLI3 NM_000168.5(GLI3): c.2023delG (p.Glu675Serfs) deletion Pathogenic rs116840744 GRCh37 Chromosome 7, 42012016: 42012016
6 GLI3 NM_000168.5(GLI3): c.2012delG (p.Gly671Glufs) deletion Pathogenic rs116840743 GRCh37 Chromosome 7, 42012027: 42012027
7 GLI3 NM_000168.5(GLI3): c.3439G> T (p.Glu1147Ter) single nucleotide variant Pathogenic rs116840768 GRCh37 Chromosome 7, 42005232: 42005232
8 GLI3 NM_000168.5(GLI3): c.2770_2771insNC_012920.1: g.12243..12314 insertion Pathogenic GRCh37 Chromosome 7, 42005900: 42005901
9 GLI3 NM_000168.5(GLI3): c.868C> T (p.Arg290Ter) single nucleotide variant Pathogenic rs121917713 GRCh37 Chromosome 7, 42079797: 42079797
10 GLI3 NM_000168.5(GLI3): c.2188_2206delCTTCCTCTGACCGATGGAG (p.Leu730Valfs) deletion Pathogenic rs116840754 GRCh37 Chromosome 7, 42007419: 42007437
11 GLI3 NM_000168.5(GLI3): c.2431+1G> A single nucleotide variant Pathogenic rs116840758 GRCh38 Chromosome 7, 41967595: 41967595
12 GLI3 NM_000168.5(GLI3): c.2620delC (p.Arg874Alafs) deletion Pathogenic rs116840761 GRCh38 Chromosome 7, 41966453: 41966453
13 GLI3 NM_000168.5(GLI3): c.2935delT (p.Cys979Alafs) deletion Pathogenic rs116840764 GRCh38 Chromosome 7, 41966138: 41966138
14 GLI3 NM_000168.5(GLI3): c.3004delG (p.Val1002Terfs) deletion Pathogenic rs116840765 GRCh37 Chromosome 7, 42005667: 42005667
15 GLI3 NM_000168.5(GLI3): c.3324C> G (p.Tyr1108Ter) single nucleotide variant Pathogenic rs116840766 GRCh37 Chromosome 7, 42005347: 42005347
16 GLI3 NM_000168.5(GLI3): c.3386_3387delTT (p.Phe1129Terfs) deletion Pathogenic rs281864935 GRCh37 Chromosome 7, 42005284: 42005285
17 GLI3 NM_000168.5(GLI3): c.3456G> T (p.Glu1152Asp) single nucleotide variant Pathogenic rs116840769 GRCh37 Chromosome 7, 42005215: 42005215
18 GLI3 NM_000168.5(GLI3): c.2351_2355delAACAA (p.Lys784Serfs) deletion Pathogenic rs116840757 GRCh37 Chromosome 7, 42007270: 42007274
19 GLI3 NM_000168.5(GLI3): c.2483delC (p.Pro828Argfs) deletion Pathogenic rs116840759 GRCh37 Chromosome 7, 42006188: 42006188
20 GLI3 NM_000168.5(GLI3): c.2567C> A (p.Ser856Ter) single nucleotide variant Pathogenic rs116840760 GRCh37 Chromosome 7, 42006104: 42006104
21 GLI3 NM_000168.5(GLI3): c.2628delC (p.Ser877Alafs) deletion Pathogenic rs116840762 GRCh37 Chromosome 7, 42006043: 42006043
22 GLI3 NM_000168.5(GLI3): c.2799C> G (p.Tyr933Ter) single nucleotide variant Pathogenic rs116840763 GRCh37 Chromosome 7, 42005872: 42005872
23 GLI3 NM_000168.5(GLI3): c.2110C> T (p.Gln704Ter) single nucleotide variant Pathogenic rs116840748 GRCh37 Chromosome 7, 42007515: 42007515
24 GLI3 NM_000168.5(GLI3): c.2146C> T (p.Gln716Ter) single nucleotide variant Pathogenic rs116840750 GRCh37 Chromosome 7, 42007479: 42007479
25 GLI3 NM_000168.5(GLI3): c.2149C> T (p.Gln717Ter) single nucleotide variant Pathogenic rs116840751 GRCh37 Chromosome 7, 42007476: 42007476
26 GLI3 NM_000168.5(GLI3): c.2058_2059delGGinsAT (p.Glu687Ter) indel Pathogenic rs116840746 GRCh37 Chromosome 7, 42011980: 42011981
27 GLI3 NM_000168.5(GLI3): c.2172_2173insC (p.Asn725Glnfs) insertion Pathogenic rs116840753 GRCh37 Chromosome 7, 42007453: 42007453
28 GLI3 NM_000168.5(GLI3): c.2197_2198delAC (p.Thr733Argfs) deletion Pathogenic rs116840755 GRCh37 Chromosome 7, 42007427: 42007428
29 GLI3 NM_000168.5(GLI3): c.2032delG (p.Asp678Thrfs) deletion Pathogenic rs116840745 GRCh38 Chromosome 7, 41972408: 41972408
30 GLI3 NM_000168.5(GLI3): c.1998_2001delCCGA (p.Pro668Leufs) deletion Pathogenic rs116840742 GRCh37 Chromosome 7, 42012038: 42012041
31 GLI3 NM_000168.5(GLI3): c.3481C> T (p.Gln1161Ter) single nucleotide variant Pathogenic rs116840770 GRCh37 Chromosome 7, 42005190: 42005190
32 GLI3 NM_000168.5(GLI3): c.1878delA (p.Lys626Asnfs) deletion Pathogenic GRCh38 Chromosome 7, 41972562: 41972562
33 GLI3 NM_000168.5(GLI3): c.4395delC (p.Ser1466Alafs) deletion Pathogenic GRCh37 Chromosome 7, 42004276: 42004276

Expression for Pallister-Hall Syndrome

Search GEO for disease gene expression data for Pallister-Hall Syndrome.

Pathways for Pallister-Hall Syndrome

Pathways related to Pallister-Hall Syndrome according to KEGG:

36
# Name Kegg Source Accession
1 Hedgehog signaling pathway hsa04340

GO Terms for Pallister-Hall Syndrome

Cellular components related to Pallister-Hall Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell projection GO:0042995 9.62 GLI2 GLI3 HYLS1 KIF7
2 axoneme GO:0005930 9.43 GLI1 GLI2 GLI3
3 cilium GO:0005929 9.35 GLI1 GLI2 GLI3 HYLS1 KIF7
4 ciliary base GO:0097546 9.33 GLI1 GLI2 GLI3
5 ciliary tip GO:0097542 8.92 GLI1 GLI2 GLI3 KIF7

Biological processes related to Pallister-Hall Syndrome according to GeneCards Suite gene sharing:

(show top 50) (show all 65)
# Name GO ID Score Top Affiliating Genes
1 heart development GO:0007507 9.92 GLI2 GLI3 MKKS SHH
2 regulation of gene expression GO:0010468 9.89 GLI3 IGF1 SHH
3 axon guidance GO:0007411 9.89 GLI2 GLI3 SHH
4 negative regulation of canonical Wnt signaling pathway GO:0090090 9.88 GLI1 GLI3 SHH
5 kidney development GO:0001822 9.84 GLI2 GLI3 SHH
6 anterior/posterior pattern specification GO:0009952 9.83 GLI2 GLI3 SHH
7 embryonic digit morphogenesis GO:0042733 9.81 GLI2 GLI3 SHH
8 odontogenesis of dentin-containing tooth GO:0042475 9.8 GLI2 GLI3 SHH
9 pattern specification process GO:0007389 9.79 GLI2 GLI3 SHH
10 lung development GO:0030324 9.78 GLI1 GLI2 GLI3 SHH
11 positive regulation of DNA replication GO:0045740 9.75 GLI1 GLI2 IGF1
12 inner ear development GO:0048839 9.74 GLI3 SHH
13 embryonic limb morphogenesis GO:0030326 9.73 GLI3 SHH
14 neural tube development GO:0021915 9.73 GLI2 GLI3
15 branching involved in ureteric bud morphogenesis GO:0001658 9.73 GLI3 SHH
16 limb development GO:0060173 9.73 GLI3 SHH
17 embryonic organ development GO:0048568 9.73 GLI3 SHH
18 liver regeneration GO:0097421 9.73 GLI1 GLI3
19 branching morphogenesis of an epithelial tube GO:0048754 9.73 GLI2 GLI3 SHH
20 smoothened signaling pathway GO:0007224 9.73 GLI1 GLI2 GLI3 SHH
21 mammary gland development GO:0030879 9.72 GLI2 GLI3
22 metanephros development GO:0001656 9.72 GLI3 SHH
23 oligodendrocyte differentiation GO:0048709 9.72 GLI3 SHH
24 neuron fate commitment GO:0048663 9.72 GLI3 SHH
25 pituitary gland development GO:0021983 9.72 GLI1 GLI2
26 positive regulation of smoothened signaling pathway GO:0045880 9.72 GLI1 KIF7 SHH
27 T cell differentiation in thymus GO:0033077 9.71 GLI3 SHH
28 hindbrain development GO:0030902 9.71 GLI2 SHH
29 proximal/distal pattern formation GO:0009954 9.71 GLI1 GLI2 GLI3
30 dorsal/ventral pattern formation GO:0009953 9.71 GLI1 GLI2 GLI3 SHH
31 negative regulation of smoothened signaling pathway GO:0045879 9.7 GLI3 KIF7
32 positive regulation of neuroblast proliferation GO:0002052 9.7 GLI3 SHH
33 regulation of smoothened signaling pathway GO:0008589 9.7 GAS1 GLI1 GLI2
34 embryonic digestive tract morphogenesis GO:0048557 9.69 GLI3 SHH
35 myoblast differentiation GO:0045445 9.69 IGF1 SHH
36 positive regulation of protein import into nucleus GO:0042307 9.69 GLI3 SHH
37 spinal cord motor neuron differentiation GO:0021522 9.69 GLI2 GLI3 SHH
38 embryonic digestive tract development GO:0048566 9.68 GLI2 GLI3
39 osteoblast development GO:0002076 9.68 GLI2 SHH
40 embryonic morphogenesis GO:0048598 9.68 GLI3 SHH
41 digestive tract morphogenesis GO:0048546 9.67 GLI1 SHH
42 dorsal/ventral neural tube patterning GO:0021904 9.67 GLI2 SHH
43 anatomical structure formation involved in morphogenesis GO:0048646 9.67 GLI2 GLI3 SHH
44 positive regulation of alpha-beta T cell differentiation GO:0046638 9.66 GLI3 SHH
45 negative thymic T cell selection GO:0045060 9.66 GLI3 SHH
46 positive regulation of T cell differentiation in thymus GO:0033089 9.65 GLI2 SHH
47 artery development GO:0060840 9.65 GLI3 SHH
48 smoothened signaling pathway involved in dorsal/ventral neural tube patterning GO:0060831 9.64 GLI2 GLI3
49 cerebellar cortex morphogenesis GO:0021696 9.64 GLI1 GLI2
50 anatomical structure development GO:0048856 9.63 GLI2 GLI3 SHH

Sources for Pallister-Hall Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....